Avdoralimab (IPH 5401) is a fully human IgGkappa monoclonal antibody that targets the complement C5a receptor 1 (C5aR1) that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research[1].
Molecular Weight:
(145.9 kDa)
Purity:
99.25
CAS Number:
[2226393-85-5]
Target:
Complement System
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
